Palvella Therapeutics (PVLA) Revenue (2014 - 2026)
Palvella Therapeutics (PVLA) recorded Revenue of $53,000 in Q1 2024, down 97.4% from $2.01 million a year earlier and down 95.9% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Revenue (2014 - 2026) Analysis & Trends
For FY2023, Palvella Therapeutics reported Revenue of $42.81 million, up 65.3% from FY2022.
- Annual Revenue has a five-year compound annual growth rate of 8.0% (FY2018 to FY2023).
- Across earlier years, Revenue came in at $25.9 million in FY2022 (-17.6%), $31.42 million in FY2021 (+7.1%), $29.32 million in FY2020 (-36.6%) and $46.28 million in FY2019 (+59.0%).
- The Q1 2024 figure is the lowest quarterly Revenue in data going back to Q1 2015.
- On a year-over-year basis, Revenue rose in four of the last eight quarters, with growth averaging 58.0%.
- Peak year-over-year performance for Revenue in the last five years was growth of 443.2% in Q2 2023, against a decline of 97.4% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.3 million (Q4 2023), $19.52 million (Q3 2023) and $20.09 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.38 Bn | 1,098.96 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 613.84 Bn | 532.37 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 502.13 Bn | 475.24 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 367.76 Bn | 322.14 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.08 Bn | 262.07 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 262.03 Bn | 235.71 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 235.81 Bn | 191.21 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Palvella Therapeutics | 1.81 Bn | 1.56 Bn | - | 1.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.97 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 520,000.00 |
| Sep 30, 2025 | 628,000.00 |
| Jun 30, 2025 | 690,000.00 |
| Mar 31, 2025 | 752,000.00 |
| Dec 31, 2024 | 281,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 19.52 Mn |
| Jun 30, 2023 | 20.09 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 5.37 Mn |
| Jun 30, 2022 | 3.70 Mn |
| Mar 31, 2022 | 11.18 Mn |
| Dec 31, 2021 | 8.44 Mn |
| Sep 30, 2021 | 4.06 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Mar 31, 2021 | 3,000.00 |
API Access
Palvella Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();